These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 16408018

  • 41. Introduction: cell-based assays for high-throughput screening.
    An WF, Tolliday NJ.
    Methods Mol Biol; 2009; 486():1-12. PubMed ID: 19347612
    [Abstract] [Full Text] [Related]

  • 42. Evaluation of virtual screening as a tool for chemical genetic applications.
    Campagna-Slater V, Schapira M.
    J Chem Inf Model; 2009 Sep; 49(9):2082-91. PubMed ID: 19702241
    [Abstract] [Full Text] [Related]

  • 43. Fragment-based activity space: smaller is better.
    Hesterkamp T, Whittaker M.
    Curr Opin Chem Biol; 2008 Jun; 12(3):260-8. PubMed ID: 18316043
    [Abstract] [Full Text] [Related]

  • 44. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 45. High-content screening moves to the front of the line.
    Haney SA, LaPan P, Pan J, Zhang J.
    Drug Discov Today; 2006 Oct; 11(19-20):889-94. PubMed ID: 16997138
    [Abstract] [Full Text] [Related]

  • 46. Assay technologies for screening ion channel targets.
    Mattheakis LC, Savchenko A.
    Curr Opin Drug Discov Devel; 2001 Jan; 4(1):124-34. PubMed ID: 11727318
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. PAINS in the assay: chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS.
    Dahlin JL, Nissink JW, Strasser JM, Francis S, Higgins L, Zhou H, Zhang Z, Walters MA.
    J Med Chem; 2015 Mar 12; 58(5):2091-113. PubMed ID: 25634295
    [Abstract] [Full Text] [Related]

  • 53. Structure-based calculation of drug efficiency indices.
    Hetényi C, Maran U, García-Sosa AT, Karelson M.
    Bioinformatics; 2007 Oct 15; 23(20):2678-85. PubMed ID: 17804436
    [Abstract] [Full Text] [Related]

  • 54. [The role of high throughput screening in the early stage of drug research].
    Keserü GM.
    Acta Pharm Hung; 2004 Oct 15; 74(1):5-10. PubMed ID: 15524043
    [Abstract] [Full Text] [Related]

  • 55. High-throughput screening using pseudotyped lentiviral particles: a strategy for the identification of HIV-1 inhibitors in a cell-based assay.
    Garcia JM, Gao A, He PL, Choi J, Tang W, Bruzzone R, Schwartz O, Naya H, Nan FJ, Li J, Altmeyer R, Zuo JP.
    Antiviral Res; 2009 Mar 15; 81(3):239-47. PubMed ID: 19118579
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Targeting disease, not disease targets: Innovative approaches in tackling neurodegenerative disorders.
    Griffioen G.
    IDrugs; 2007 Apr 15; 10(4):259-63. PubMed ID: 17390249
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Type I methionine aminopeptidase from Saccharomyces cerevisiae is a potential target for antifungal drug screening.
    Chen LL, Li J, Li JY, Luo QL, Mao WF, Shen Q, Nan FJ, Ye QZ.
    Acta Pharmacol Sin; 2004 Jul 15; 25(7):907-14. PubMed ID: 15210064
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.